Orphan drug development in alpha-1 antitypsin deficiency

Alpha-1 antitrypsin deficiency (AATD, OMIM #613490) is a rare metabolic disorder affecting lungs and liver. The purpose of this study is to assess the impact of the US orphan drug act on AATD by providing a quantitative clinical-regulatory insight into the status of FDA orphan drug approvals and des...

Descripción completa

Detalles Bibliográficos
Autores principales: Trudzinski, Franziska C., Presotto, Maria Ada, Buck, Emanuel, Herth, Felix J. F., Ries, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477815/
https://www.ncbi.nlm.nih.gov/pubmed/36109566
http://dx.doi.org/10.1038/s41598-022-19707-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477815/
https://www.ncbi.nlm.nih.gov/pubmed/36109566
http://dx.doi.org/10.1038/s41598-022-19707-2

Ejemplares similares